ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $945,358 | -69.6% | 86,334 | -63.2% | 0.00% | -50.0% |
| Q2 2023 | $3,106,991 | -21.0% | 234,667 | -18.8% | 0.00% | -33.3% |
| Q1 2023 | $3,931,725 | -14.1% | 288,885 | +23.3% | 0.00% | -25.0% |
| Q4 2022 | $4,575,801 | -18.4% | 234,296 | -20.4% | 0.00% | 0.0% |
| Q3 2022 | $5,606,000 | +116.5% | 294,253 | +134.1% | 0.00% | +100.0% |
| Q2 2022 | $2,589,000 | +148.7% | 125,702 | +288.5% | 0.00% | +100.0% |
| Q1 2022 | $1,041,000 | -89.3% | 32,353 | -84.5% | 0.00% | -80.0% |
| Q4 2021 | $9,708,000 | -13.0% | 208,500 | -49.6% | 0.01% | -28.6% |
| Q3 2021 | $11,164,000 | +0.6% | 413,472 | -4.4% | 0.01% | 0.0% |
| Q2 2021 | $11,093,000 | +819.1% | 432,484 | +1125.1% | 0.01% | +600.0% |
| Q1 2021 | $1,207,000 | +977.7% | 35,303 | +968.5% | 0.00% | – |
| Q4 2020 | $112,000 | +761.5% | 3,304 | +544.1% | 0.00% | – |
| Q3 2020 | $13,000 | – | 513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |